Introduction
The complement system is an integral part of the innate antimicrobial immune defence and mediates humoral and cellular interactions within the immune response, including chemotaxis, phagocytosis, cell adhesion, and B cell differentiation. 1 Complement may be activated via three different routes, the classical pathway, the alternative pathway, and the recently described lectin pathway. The classical activation pathway is initiated by binding of the hexaoligomeric recognition molecule C1q to immune complexes via its globular heads. This effects a conformational change of its collagenous stalks which in turn leads to the activation of the C1q-associated serine protease complexes C1r 2 and C1s 2 . Of these, C1r cleaves and activates the zymogen C1s. Activated C1s subsequently cleaves C4 and C4b bound C2 to generate the C3 con-vertase, C4b2b, and the C5 convertase, C4b2b(C3b) n . The alternative pathway forms an amplification loop of complement activation and is initiated by binding of the complement activation product C3b to Factor B. The subsequent cleavage of Factor B by Factor D forms an enzymatically active complex, C3bBb, which converts native C3 to C3b. Accumulation of multiple C3b molecules in proximity of the alternative pathway convertase C3bBb allows the complex to cleave and activate the fifth component of complement, C5.
The lectin pathway can be activated in the absence of immune complexes and is initiated by the recognition of carbohydrate structures present on microbial organisms via macromolecular complexes present in body fluids. These complexes are composed of a multivalent pattern recognition subunit and associated serine proteases which initiate complement activation upon binding of the recognition subunits to microbial oligosaccharide structures. To date, two pattern recognition components of the lectin activation pathway have been described, the well characterised plasma glycoprotein mannan-binding lectin (MBL) 2 and ficolin p35, 3 both members of the collectin family, 4 ,5 yet differing in their binding specificities to microbial surface oligosaccharides. As these vary considerably amongst members of the collectin family, the presence of more than one recognition subunit may result in a wider spectrum of microbial surfaces recognised by the lectin pathway activation complexes. MBL forms a hexoidal macromolecular complex of six structural subunits each composed of three identical polypeptide chains. This associates with two distinct serine proteases, the MBL-associated serine proteases-1 and -2 (ie, MASP-1, MASP-2), and a 19 kDa MASP-2 related plasma protein, termed MAp19 or sMAP. 6 No detailed information is yet available on the stoichiometry of lectin pathway activation complexes formed with ficolin p35. It is, however, clear that ficolin p35 complexes associate with MASP-1, MASP-2 and MAp19/sMAP and initiate the lectin pathway via the aforementioned serine proteases. 3 In vitro, purified and recombinant MASP-2 was shown to cleave the fourth and second component of complement (ie, C4 and C2) in absence of MASP-1. [6] [7] [8] The sequential proteolytic cleavage of C4 and C4b bound C2 to form the C3 convertase, C4b2b, and the C5 convertase, C4b2b(C3b), respectively, is the essential step by which the lectin pathway activation complex as well as the classical pathway activation complex initiate further downstream activation of complement. 7, 8 The potential of MASP-2 to activate complement in absence of MASP-1 in vitro is supported by the analysis of sera of a recently established MASP-1 deficient mouse strain, which exhibits effective lectin pathway activation under physiological conditions. 9 Thus, MASP-2 is the effector component of the lectin pathway of complement activation. MASP-1 and MAp19 are constitutive components of the lectin pathway activation complexes, their specific functional role(s), however, have yet to be defined.
We have previously shown that a single structural MASP2 gene of approximately 20 kb on chromosome 1p36.23-31 is transcribed and processed to generate two gene products, a 2.6 kb MASP-2 mRNA, encoding the 76 kDa MASP-2 serine protease, or an abundant 1.0 kb mRNA transcript, encoding a truncated MASP-2 related plasma protein of 19 kDa devoid of a serine protease domain, termed MAp19 or sMAP. [10] [11] [12] [13] The present report amends and completes our previously presented organisational map (based solely on genomic PCR) 10, 11 by a comparative analysis of overlapping sequences obtained from human genomic DNA isolated as independent YAC, BAC and FixII clones. These represent approximately 222 kb of the chromosomal area 1p36.2-3. Furthermore, we present putative promoter elements responsible for the strict hepatic expression pattern of MASP-2 and MAp19 mRNA.
Results

Human MASP2 gene organisation
The revised multi-exon structure of the human MASP2 gene (encompassing approximately 20 kb) is presented as derived from sequence analysis of six overlapping clones (Figure 1a and b) .
The 5Ј boundary of exon a (62 bp) was determined by mapping the transcription initiation start site. From two independent 5Ј RACE reactions performed on human liver cDNA, it was determined to lie 57 bp upstream of the translation initiation codon (Figure 2 ). In comparison to the published sequences for human MASP-2 and MAp19/sMAP mRNA species, the 5Ј UT region of human MASP-2 mRNA (Y09926) could be extended by 37 bp and that of human MAp19/sMAP mRNA by 41 bp (Y18281) and 31 bp (AB008047), respectively. The sequence coding for the signal peptide is split by an intron of 83 bp (Figure 1a) . Exon b codes for the remainder of the signal peptide (R)LLTLLGLLCGSVA and the N-terminal 63 residues of the CUB I domain. The C-terminal 59 residues of the CUB I domain are encoded by exon c, separated from exon b by 157 bp and from exon d, the single exon coding for the EGF-like domain, by 1016 bp. The alternative splice/polyadenylation exon e (which contains coding sequence for the four C-terminal amino acids of MAp19 not found in MASP-2, namely glutamic acid, glutamine, serine, and leucine, and sequence of the 3Ј UT region specific for MAp19 mRNA) follows after 454 bp of intronic sequence. The 3Ј boundary of exon e is determined by the position of the poly(A) addition site 14 noted in the human MAp19 mRNA transcripts with the accession numbers Y18281-Y18284. 1262 bp further downstream, sequence for the second CUB structural domain is split by an intron of 316 bp (exon f, 197 bp; exon g, 148 bp, respectively). An intron of 1997 bp follows (AJ299718). The two CCP domains of MASP-2 are encoded by two exons each over a stretch of 7.6 kb, exon h (119 bp) and exon i (79 bp), exon j (135 bp) and exon k (75 bp), respectively. 2527 bp further downstream, exon l encodes the serine protease domain of MASP-2 and contains the 3Ј UT region specific for MASP-2 mRNA. The 3Ј boundary of exon l is determined from the position of the poly (A) addition site 14 found in cDNA clones Y09926, phl-1, phl-2, phl-3. 15 Exons b-l are preceded by polypyrimidine rich tracts. Sequence comparison of the clones aligned in Figure 1 revealed only two variants (transitions) within the coding sequence of the MASP2 gene: the codon for the amino acid position 362 of the mature MASP-2 protein is GTG (valine) in AL109811 and GCG (alanine) in AJ300188, respectively; the codon for amino acid position 478 is TCC (serine) in AL109811 and TCT (serine) in AJ300188, respectively.
The codon phases (positions of introns within the codon) are given in Table 1 . They are identical for the human MASP2, MASP1, and C1s genes in the orthologous exonic composition represented in MASP2 exons a, b, c, d, f, g, h, i, j, and k. 16 The codon phase at the 5Ј end of exon l is also identical for the orthologous position in the human C1r gene. 17 A GC level of 50.37% was determined for sequence encompassing the MASP2 gene (−2137 from transcription start site to 167 bp past exon l, ie a total of 19980 bp; http://ftp.genome.washington.edu/cgi-bin/RepeatMasker). In keeping with this high GC content, this area is characterised by the abundance of 'short interspersed nuclear elements', especially ALU repeats (36.01% of the sequence) and MIR (1.59%), and scarce 'long interspersed nuclear elements', LINE2 (1.46%). Within 1.2 kb 5Ј of the determined transcription start site three potential promoter sites (with a score cut-off of 0.9, 0.99, and 1.0, respectively) are predicted by a human promoter analysis programme (http://www.fruitfly. org/seqFtools/promoter.html). 18 There are two putative GC-box motifs. 19 Several potential transcription factor binding sequences are revealed in their vicinities (http://bimas.dcrt.nih.gov/molbio/signal/) 20, 21 ( Figure 2 ). Most importantly, among the latter, consensus sequences for liver-specific (LF-A1 and TGT3) or -enriched transcription factors (HNF4, and HNF5, respectively, http://www.cbil.upenn.edu/tess/) are contained which may play a role in determining the liver specific expression of MASP-2 and MAp19 mRNA. 10, 12 Clone RP11-99P18 (AJ300188) only covers sequence for the 3Ј end of the MASP2 gene including exons l, k, and j, and 1.5 kb intronic sequence prior to exon j ( Figure 1 ). As indicated in Figure 3 , sequence encompassing the promoter area of the MASP2 gene ( Figure 2 ) and the entire genomic sequence for exons a through i (including the alternative splice exon e) are replaced by a shortened, unrelated sequence of 1.3 kb. At its boundaries with the known MASP2 gene sequence (100% identical in overlapping parts), there is an increasing number of nucleotide mismatches towards a sequence which is composed of 48% ALU repeats and 6.3% LINE2 repeats (http:// ftp.genome.washington.edu/cgi-bin/RepeatMasker). Figure 3 (a and b) gives an overview of the MASP2 gene cluster, as determined from sequence of overlapping clones characterised in this work. The MASP2 gene is located in close vicinity to non-complement genes.
Genetic neighbourhood of the MASP2 gene
FRAP is a phospatidylinositol kinase conserved in yeast, 22 cryptococcus neoformans, 23 rat, 24 and bovidae 25 and is involved in G1 cell cycle progression. 26 Its gene, FRAP1, is located in the vicinity of a cytogenetic breakpoint. 27 It has been mapped to chromosomal location 1p36.2 28 homologue, Rrp6p, which is required for processing of 5.8 S rRNA prior to ribosomal subunit assembly. 32 Its gene, PMSCL2, has been located to human chromosome 1p36 and to mouse chromosome 4q27 (which is syntenic to the human gene location). 33 Two gene bank entries for mRNA transcripts of this gene, X66113 and L01457, sharing the same 5Ј and 3Ј UT regions and differing in the presence or absence of coding sequence for 25 amino acids were analysed in comparison with the complete transcription unit of PMSCL2. The two mRNA transcripts are alternative products from the same gene arising from in-frame inclusion or skipping of the nineteenth exon (codon phase 0).
TAR DNA binding protein of 43 kDa is a transcription factor that binds specifically to pyrimidine-rich motifs contained in the HIV-1 long terminal repeat and acts to repress gene expression. 34 Its gene is termed TARDBP. The International Radiation Hybrid Mapping consortium has mapped the TARDBP gene to chromosome 20 (http://www.ncbi.nlm.nih.gov/omim/). Indeed, databank search (http://www.sanger.ac.uk/HGP/Chr20/) using the full-length mRNA sequence (AL050265) retrieves the following human bacterial artificial chromosome (BAC) clone, RP11-318P23 (AL359954). However, the degree of identity is between 86 and 95%, whereas the TARDBP mRNA sequence (AL050265) is 98-100% identical to corresponding sequence represented in PAC clone RP4-635E18 (AL109811), mapping to chromosome 1p36.11-31.
The chromosomal localisation of the gene for 'corneaderived transcript 6', CDT6 (Y16132), has not previously been assigned. The single report in the literature ident- ifies CDT6 as a novel gene whose translational product shows homology to angiopoietins 1 and 2 and is characterised by a coiled-coil structural domain and a fibrinogen-like domain. 35 The gene for CDT6 lies within a 25 kb intron of the FRAP1 gene, in opposite transcriptional orientation (Figure 3 ).
Discussion
The MASP2 gene extends over approximately 20 kb and is much smaller than the MASP1 gene (about 72 kb as seen from sequence made available by the Human Genome Sequencing Project, accession number AC007920) owing to smaller introns. The human C1s gene comprises approximately 13 kb. 16 Like the mRNA for the serine protease C1s, the MASP-2 mRNA transcript is encoded by 12 exons. There is one additional exon in the MASP2 gene to allow generation of the alternative splice and polyadenylation product, MAp19/sMAP. In the C1s and the MASP2 gene, each of the two CUB structural domains as well as each of the two CCP modules are encoded by two exons each. The EGF-like domain is encoded by one exon only. Likewise, the enzymatically active protease domain is encoded by one exon only and clearly distinguishes the C1s and MASP2 genes from the MASP1 gene, in which the protease domain is encoded by six exons. 16 A previously published comparative analysis of the genomic organisation of the serine protease domain of MASP-2 in mouse and Xenopus and of MASPs in carp, shark, and lamprey Table 1 Codon phases within the human MASP2 gene Splice donor and acceptor sequences of all exons are compiled. The arrows indicate the alternative polyadenylation/splicing event that takes place in the hnRNA to generate either the MAp19 or MASP-2 mRNA. The position of the intron within the respective codon is given to the right; codon phase 0 and I denote a position of the intronic sequence before and after the first base, respectively. revealed that these MASP genes belong to the so-called AGY lineage of thrombin-like serine proteases. The members of this lineage are characterised by an AGY codon at the active site serine and a single exon coding for the protease domain. 16 C1r was also shown to possess an intronless protease domain, 36 its active site serine residue is also encoded by an AGY triplet. The close proximity of the human C1r and C1s genes, both of the AGY lineage (in 5Ј → 3Ј (C1r gene) and 3Ј → 5Ј (C1s gene) orientation, at an intergenic distance of 9.5 kb 37 ), suggested that both Genes and Immunity genes are the result of a gene duplication event 38 and have remained closely linked on chromosome 12p13. 39 MASP-1, by contrast, belongs to the TCN lineage of trypsin-like serine proteases. 16 Taking this into account, 40 a model for the evolution of the MASP1, MASP2, C1r, and C1s genes was proposed which involves events such as mutation, retrotransposition, and duplication from an ancestral gene of the TCN type lineage showing a split gene organisation for the protease domain. 16, 17, 41, 42 The identical codon phases in the orthologous coding sequences of the MASP1, MASP2, C1s genes, and the partially characterised C1r gene underline the likelihood of such a genesis. The phenomenon of exon shuffling may have to be added to these events: 43 symmetric exons, ie exons for which the phase of the 5Ј intron is identical to the phase of the 3Ј intron, will spread more easily by exon shuffling than nonsymmetric ones. 44 Within the MASP2 gene, exons d, e, j, and k are symmetric, ie phase correlated, exons (coding for the EGF-like domain, the MAp19 specific C-terminus, and all of CCP II). By contrast, introns that lie in phase 0 (ie between codons), are said to be ancient, ie originally present in the progenote, and are probably more related to structural modules of the protein. 45 In the MASP2 gene, phase 0 introns are found between the exons coding for CUB I, CUB II, and CCP I, respectively.
The MASP2 gene lies in a gene-rich area of chromosome 1, 46 in close proximity to non-complement genes, such as the gene coding for TAR DNA binding protein, the gene coding for the 100 kDa Polymyositis-Scleroderma autoantigen, the gene coding for FRAP kinase which harbours in one of its introns the gene for CDT6. All of these genes have a split exon architecture.
In a wider genetic context, the detection on 1p35-36.2 of several and polymorphic pseudogenes of the macrophage stimulating protein gene has lead to the concept that recombination may occur frequently between these repeated sequences. 47 In addition, a PAC clone from this chromosomal area (Z98257) contains sequence with 81-96% identity to a human endogenous retrovirus type C oncovirus sequence (M74509). An adenoviral integration site has been mapped to 1p36.1. 48 The cytogenetic aberration described in neuroblastomas is a deletion of the short arm of chromosome 1. 49 This deletion encompasses the MASP2 gene locus (the MASP2 gene is at 5.66 cR from the marker D1S548 13 ) as seen from an analysis of several framework maps (http://www.ncbi.nlm.nih.gov/ genemap/map.cgi for chromosome 1). 28, 49 The significance of this is not yet clear. Here, it is of interest to note the substitution of part of the MASP2 gene observed in clone RP11-99P18 (AJ300188), which encompasses the promoter region of the MASP2 gene, exons a through i, and includes most of the intron prior to exon j which codes for the N-terminal part of CCP II. Analysis of this sequence area reveals that there is sequence identity over a stretch of 1.5 kb for the 3Ј part of the intron i/j of the MASP2 gene and a stretch of 4.3 kb for the 5Ј part of the intergenic region to the PMSCL2 gene, respectively. Approaching the divergent sequence of 1.3 kb (solely composed of repetitive elements) from either side, there is an increasing number of nucleotide mismatches. The origin of the divergent organisation of the MASP2 gene locus in this BAC clone is presently investigated by sequencing two overlapping BACs of the same human BAC library from which clone RP11-99P18 was isolated.
The serine proteases of the classical and lectin pathway of complement activation have a similarity score between 39 and 52%. 15 Their genes belong to a multigene family. Genes coding for various types of trypsinogen are also members of this family. Trypsin, composed solely of a serine protease domain (of the TCN type and encoded by five exons, the boundaries differ from the ones found in the orthologous part of the MASP1 gene coding for the serine protease domain), is thought to be the primordial enzyme present before the emergence of complement serine proteases, and novel substrate specificities are thought to have been introduced by the evolutionary anteposition of certain modular domain structures found in, eg, MASP-2, MASP-1, C1r, and C1s. Recent work emphasises the importance of residue 225 (chymotrypsin numbering) in serine proteases. 50 While degradative enyzmes such as trypsin have a proline residue at this position, P225, a tyrosine is found in MASP-1, MASP-2, C1r, C1s (and thrombin), Y225. Y225 allows Na + binding near the primary specificity site and thus enhances catalytic activity. It is thought that the mutation P225 to Y225 occurred in prevertebrates in the face of evolutionary pressures, prior to the conversion of the codon for the active site serine (TCN to AGY) in more specialised serine proteases found in vertebrates. 50 The concomitant presence of members of unrelated multigene families in the vicinity of the MASP1, MASP2, Table 2 Compilation of positional overlap of human genes belonging to four different multigene families Presented on the left are the genes for the serine proteases MASP-2, MASP-1, C1r, C1s, and two trypsins; these are compared against members of three unrelated gene families, a glucose transporter gene family (SLC2A), a chloride channel gene family (CLCN), and the tumor necrosis factor receptor gene family (TNFR), and their respective chromosomal locations are indicated.
C1r, C1s, and trypsinogen genes would lend support to the hypothesis of a joint ancestry of these genes and weaken the theoretical possibility of a convergent evolution of unrelated genes. In search of these, strikingly overlapping chromosomal positions have been found for the serine protease genes of interest to this work, two of the trypsinogen genes, 51 the genes for certain isoforms of a glucose transporter 52 and of a chloride channel 53 as well as for the genes for the two TNF receptors (http://www. ncbi.nlm.nih.gov/omim/, http://www.ncbi.nlm.nih. gov/genemap99/) 54, 55 (Table 2) . We propose that the consideration of such neighbouring genes which are equally members of multigene families should be included in phylogenetic analyses.
Materials and methods
RACE
Initiation of transcription of the human MASP2 gene 10, 11 was mapped by RACE technology using 5Ј RACE System for Rapid Amplification of cDNA Ends (Version 2.0) from Life Technologies (Paisley, UK). Total RNA prepared from human liver tissue 56 was transcribed to cDNA using a MASP-2 mRNA specific antisense oligonucleotide (5Ј GGAGAGTTTGGGATACGGCCGTGG GTA 3Ј, bp pos. 617-643, accession number Y09926). The single strand cDNA was purified and dC-tailed according to the manufacturer's protocol. An anchor primer annealing to the homopolymeric tail and two other, nested MASP-2/MAp19 specific oligonucleotides (5Ј GCGTGGCCAG CACCTTGGCCCC 3Ј, bp pos. 265-286 of Y18281, 5Ј GCGA GTAGAAAGTGTCCTTGC 3Ј, bp pos. 326-346 of Y18281) positioned 3Ј of the above oligonucleotide were used for two independent cyclic amplification reactions. Two distinct amplification products of 320 bp and 380 bp, respectively were subcloned in pGEMTeasy vector (Promega, Southampton, UK) and analysed by double stranded cycle sequencing.
Cloning of the MASP2 gene
Human bacterial artificial chromosome (BAC) clones were isolated by screening a human RP11 BAC library using a radiolabeled cDNA probe specific for the coding Genes and Immunity region of the serine protease domain of MASP-2 (Research Genetics, Huntsville, Alabama, USA). The clones were verified by colony PCR using MASP-2 specific oligonucleotides (5Ј ACCT GGTGATTTTCCTTGG 3Ј, bp. pos. 1372-1390 of Y09926 and 5Ј GTCACTCT CGTGGTTTATG 3Ј, bp. pos. 2278-2296 of Y09926) and Southern blotting. Partial primary structure for the MASP2 gene was established from overlapping subclones obtained from a shotgun library constructed of one BAC clone, RP11-99P18. Double stranded sequencing and analysis were performed using automated sequencer ABI 377 and Sequencher 3.0 programme (Gene Codes Corporation, MI, USA), respectively. In parallel, two clones, ø4-12 and ø2-2, were isolated from a human Fix II genomic library using a MASP-2 cDNA probe and analysed by restriction mapping and sequencing. One clone, AJ297949, was obtained by cyclic amplification of human genomic DNA using MASP-2 specific oligonucleotides (5Ј GCGCCCACCTGCGACCACCAC 3Ј, bp pos. 461-481 of Y09926 and 5Ј TCCTGATTCATCTGTGACAAAGG 3Ј, bp pos. 846-868 of Y09926) and characterised by restriction mapping and sequencing.
